Arch. med. vet.  vol.48 no.3; Resumen: S0301-732X2016000300010
Revistas Electrónicas UACh
Web Sistema de Bibliotecas UACh
Formulario de Contacto Revistas Electrónicas UACh (OFF)
Revistas Electrónicas UACh - Archivos de medicina veterinaria
 
vol.48 no.3Facilidad de manipulación, respuesta fisiológica, lesiones en la piel y calidad de la carne de los cerdos transportados en dos tipos de camionesFrecuencia y comportamiento frente a antimicrobianos de especies termófilas de Campylobacter aisladas de pollos de traspatio en Ecuador  Indice de autoresIndice de materiabúsqueda de artículos
Inicio revistalista alfabética de revistas  
-

Archivos de medicina veterinaria
ISSN 0301-732X versión impresa

 
  Como citar este artículo
  Agregar a favoritos
  Enviar a e-mail


Resumen

DORNER, CA, RICK, MC y JUDY, CE. Evaluación de la infusión de tiludronato en caballos previamente sometidos a cintigrafía ósea. Arch. med. vet., 2016, vol.48, no.3, p.305-310. ISSN 0301-732X.

This study was performed to evaluate the systemic short-term effects of tiludronate intravenous infusion on serum biochemical variables when administered as one single-dose in horses that undergo bone scintigraphy within 24 to 36 hours prior to treatment. Thirty-eight horses were enrolled in the study. Fifteen horses received a dose of technetium (0.3 mCi/kg), MDP (20 mg; medronate) and another fifteen horses received technetium (0.3 mCi/kg), MDP (20 mg), and furosemide (1 mg/kg). Then, 24 to 36 hours after the bone scintigraphy, eight horses were selected and received tiludronate (500 mg in 5L of 0.9% NaCl). Blood samples were collected 15 minutes prior, 24 and 48 hours after the treatment and a chemistry panel was assayed on the day of collection. Serum chemistry values were not significantly different between horses receiving tiludronate and those in both control groups. Additionally, one horse showed mild transient signs of colic recorded as pacing and stretching in the stall after 3 hours the injection of the tiludronic acid. The results suggest that tiludronate can be administered safely as one single dose in horses having undergone recent bone scintigraphy without additional complications or detrimental effect other than those previously described for the drug.

Palabras Clave: horse; bisphosphonates; tiludronate; bone scintigraphy.

        · resumen en español     · texto en inglés     · pdf en inglés


© 2017 • Facultad de Ciencias Veterinarias, Universidad Austral de Chile
Teléfono/Fax: 56 63 221459 • Casilla 567 • Campus Isla Teja S/N • Valdivia • Chile
E-mail: